AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

European Medicines Agency decision P/336/2010 of 22 Dec 2010 on the granting of a product specific waiver for interferon alpha 2b (EMEA-001036-PIP01-10) in accordance with Regulation (EC) No 1901/2006 of the European Parliament and of the Council.

Chemical Business Newsbase

| January 26, 2011 | COPYRIGHT 2000 Elsevier Engineering Information, Inc. (Hide copyright information)Copyright

On 26 Jan 2011, the European Medicines Agency published decision P/336/2010 of 22 Dec 2010 on the granting of a product specific waiver for interferon alpha 2b (EMEA-001036-PIP01-10). A waiver for interferon alpha 2b, vaginal cream, vaginal use, was granted. This decision is addressed …

Related articles from newspapers, magazines, journals, and more
EU medicines agency publishes product alert for Aventis' Arava drug.(European...
Newspaper article from: M2 Europharma March 26, 2001 700+ words
European Medicines Agency decision of 3 Nov 2008 on the application for...
News wire article from: Chemical Business Newsbase January 7, 2009 700+ words
European Medicines Agency decision of 14 Oct 2008 on the application for...
News wire article from: Chemical Business Newsbase November 24, 2008 700+ words
European Medicines Agency decision of 22 Oct 2008 on the application for...
News wire article from: Chemical Business Newsbase November 24, 2008 700+ words
European Medicines Agency decision of 14 Oct 2008 on the application for...
News wire article from: Chemical Business Newsbase November 24, 2008 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily